Article
The c-Kit/D816V mutation eliminates the differences in signal transduction and biological responses between two isoforms of c-Kit.
Experimental Clinical Chemistry, Department of Laboratory Medicine, Malmö University Hospital, Lund University, SE-205 02 Malmö, Sweden.
Cellular signalling (impact factor:
4.09).
12/2008;
21(3):413-8.
DOI:10.1016/j.cellsig.2008.11.008
pp.413-8
Source: PubMed
-
Citations (0)
-
Cited In (0)
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
alternative mRNA splicing
amino acids
c-Kit/GNNK+
c-Kit/GNNK-
c-Kit/GNNK- induced
cell factor
D816V/GNNK+ constitutively phosphorylated Gab2
different signaling proteins
downstream signal transduction
human malignancies
Kit gene
mutant receptor
oncogenic c-Kit mutant D816V
signal transduction
stronger proliferation
two GNNK isoforms
two isoforms
tyrosine kinase receptor
wild-type c-Kit
wild-type c-Kit isoforms